Top

Osteoporosis International

Published in:

01-12-2008 | Original Article

Replication of associations between LRP5 and ESRRA variants and bone density in premenopausal women

Authors: S. Giroux, L. Elfassihi, D. E. C. Cole, F. Rousseau

Published in: Osteoporosis International | Issue 12/2008

Abstract

Summary

Replication is a critical step to validate positive genetic associations. In this study, we tested two previously reported positive associations. The low density lipoprotein receptor-related protein 5 (LRP5) Val667Met and lumbar spine bone density are replicated. This result is in line with results from large consortiums such as Genomos. However, the estrogen-related receptor alpha (ESRRA) repeat in the promoter is not replicated although the polymorphism studied was functional and could have been a causative variant.

Introduction

We sought to validate associations previously reported between LRP5 V667M polymorphism and lumbar spine (LS, p = 0.013) and femoral neck (FN, p = 0.0002) bone mineral density (BMD), and between ESRRA 23 base pair repeat polymorphism and LS BMD (p = 0.0036) in a sample of premenopausal Caucasian women using an independent sample.

Methods

For the replication sample, we recruited 673 premenopausal women from the Toronto metropolitan area. All women were Caucasian and had BMD measured. LRP5 V667M was genotyped by allele-specific PCR and ESRRA repeats by sizing of PCR products on agarose gels.

Results

We reproduced the same association as we reported previously between LRP5 V667M and LS BMD (p = 0.015) but not with FN BMD (p = 0.254). The combined data from the two populations indicate an effect size of 0.28SD for LS BMD (p = 0.00048) and an effect size of 0.26 SD for FN BMD (p = 0.00037). In contrast, the association we reported earlier between ESRRA repeats and LS BMD was not replicated in the sample from Toronto (p = 0.645).

Conclusions

The association between LRP5 V667M and LS BMD is confirmed but not that between ESRRA repeats and LS BMD. This result indicates that it is imperative to validate any positive association in an independent sample.

Pocock NA, Eisman JA, Hopper JL et al (1987) Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80:706–710CrossRef

Brown LB, Streeten EA, Shapiro JR et al (2005) Genetic and environmental influences on bone mineral density in pre- and post-menopausal women. Osteoporos Int 16:1849–1856PubMedCrossRef

Danielson ME, Cauley JA, Baker CE et al (1999) Familial resemblance of bone mineral density (BMD) and calcaneal ultrasound attenuation: the BMD in mothers and daughters study. J Bone Miner Res 14:102–110PubMedCrossRef

Hunter DJ, de Lange M, Andrew T et al (2001) Genetic variation in bone mineral density and calcaneal ultrasound: a study of the influence of menopause using female twins. Osteoporos Int 12:406–411PubMedCrossRef

Colhoun HM, McKeigue PM, Davey Smith G (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361:865–872PubMedCrossRef

Tabor HK, Risch NJ, Myers RM (2002) Opinion: candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 3:391–397PubMedCrossRef

Chanock SJ, Manolio T, Boehnke M et al (2007) Replicating genotype-phenotype associations. Nature 447:655–660PubMedCrossRef

Giroux S, Elfassihi L, Cardinal G et al (2007) LRP5 coding polymorphisms influence the variation of peak bone mass in a normal population of French-Canadian women. Bone 40:1299–1307PubMedCrossRef

Laflamme N, Giroux S, Loredo-Osti JC et al (2005) A frequent regulatory variant of the estrogen-related receptor alpha gene associated with BMD in French-Canadian premenopausal women. J Bone Miner Res 20:938–944PubMedCrossRef

10.

Rubin LA, Hawker GA, Peltekova VD et al (1999) Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res 14:633–643PubMedCrossRef

11.

Ferrari SL, Deutsch S, Choudhury U et al (2004) Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 74:866–875PubMedCrossRef

12.

Koller DL, Ichikawa S, Johnson ML et al (2005) Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res 20:75–80PubMed

13.

Koay MA, Woon PY, Zhang Y et al (2004) Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 19:1619–1627PubMedCrossRef

14.

van Meurs JB, Rivadeneira F, Jhamai M et al (2006) Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Miner Res 21:141–150PubMedCrossRef

15.

Ezura Y, Nakajima T, Urano T et al (2007) Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women. Bone 40:997–1005PubMedCrossRef

16.

Xiong DH, Lei SF, Yang F et al (2007) Low-density lipoprotein receptor-related protein 5 (LRP5) gene polymorphisms are associated with bone mass in both Chinese and whites. J Bone Miner Res 22:385–393PubMedCrossRef

17.

Koay MA, Tobias JH, Leary SD, et al. (2007) The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood. Calcif Tissue Int

18.

Liu D, Zhang Z, Teng CT (2005) Estrogen-related receptor-gamma and peroxisome proliferator-activated receptor-gamma coactivator-1alpha regulate estrogen-related receptor-alpha gene expression via a conserved multi-hormone response element. J Mol Endocrinol 34:473–487PubMedCrossRef

19.

Laganiere J, Tremblay GB, Dufour CR et al (2004) A polymorphic autoregulatory hormone response element in the human estrogen-related receptor alpha (ERRalpha) promoter dictates peroxisome proliferator-activated receptor gamma coactivator-1alpha control of ERRalpha expression. J Biol Chem 279:18504–18510PubMedCrossRef

20.

Bonnelye E, Merdad L, Kung V et al (2001) The orphan nuclear estrogen receptor-related receptor alpha (ERRa) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J Cell Biol 153:971–983PubMedCrossRef

21.

Jamal SA, Ridout R, Chase C et al (1999) Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res 14:2143–2149PubMedCrossRef

22.

Peltekova VD, Rubin L, Uitterlinden AG et al (1997) Direct haplotyping at the vitamin D receptor locus improves genetic resolution. J Bone Miner Res 12:494–495PubMedCrossRef

23.

Guo SW, Thompson EA (1992) Performing the exact test of Hardy–Weinberg proportion for multiple alleles. Biometrics 48:361–372PubMedCrossRef

24.

Scillitani A, Jang C, Wong BY et al (2006) A functional polymorphism in the PTHR1 promoter region is associated with adult height and BMD measured at the femoral neck in a large cohort of young caucasian women. Hum Genet 119:416–421PubMedCrossRef

25.

Hawker GA, Jamal SA, Ridout R et al (2002) A clinical prediction rule to identify premenopausal women with low bone mass. Osteoporos Int 13:400–406PubMedCrossRef

26.

Patel MS, Cole DE, Smith JD et al (2000) Alleles of the estrogen receptor alpha-gene and an estrogen receptor cotranscriptional activator gene, amplified in breast cancer-1 (AIB1), are associated with quantitative calcaneal ultrasound. J Bone Miner Res 15:2231–2239PubMedCrossRef

27.

Xiong DH, Shen H, Zhao LJ et al (2006) Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction. J Bone Miner Res 21:1678–1695PubMedCrossRef

28.

Ralston SH (2007) Genetics of osteoporosis. Proc Nutr Soc 66:158–165PubMedCrossRef

29.

van Meurs JB et al (2007). ASBMR 29th Annual Meeting Honolulu, Hawaii, USA. Abstract # 1107.

30.

Bonnelye E, Vanacker JM, Dittmar T et al (1997) The ERR-1 orphan receptor is a transcriptional activator expressed during bone development. Mol Endocrinol 11:905–916PubMedCrossRef

31.

Ioannidis JP, Ntzani EE, Trikalinos TA et al (2001) Replication validity of genetic association studies. Nat Genet 29:306–309PubMedCrossRef

Title: Replication of associations between LRP5 and ESRRA variants and bone density in premenopausal women
Authors: S. Giroux
L. Elfassihi
D. E. C. Cole
F. Rousseau
Publication date: 01-12-2008
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 12/2008
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-008-0617-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Replication of associations between LRP5 and ESRRA variants and bone density in premenopausal women

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2008

Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis

Hip fractures cluster in space: an epidemiological analysis in Portugal

Measuring serum calcium before and after teriparatide treatment

Outcomes after switching from one bisphosphonate to another in 146 patients at a single university hospital

Muscle power is related to tibial bone strength in older women

Effective doses for strontium ranelate